Characteristics of human failing permeabilized myocytes before and after PKA
| Human samples . | Myofibrillar preparations . | |
|---|---|---|
| Before . | After PKA . | |
| n | 8 | |
| Fiber length (µm) | 153 ± 8 | |
| Fiber width (µm) | 27 ± 2 | |
| Resting sarcomere length (µm) | 2.20 ± 0.02 | |
| Passive force (µN) | 0.53 ± 0.08 | 0.58 ± 0.08 |
| Passive tension (kN/m2) | 1.32 ± 0.18 | 1.39 ± 0.14 |
| Max force (µN) | 14.0 ± 2.3 | 14.7 ± 2.2 |
| Max tension (kN/m2) | 30.9 ± 3.5 | 36.6 ± 4.6a |
| ktr @ pCa 4.5 (s−1) | 0.515 ± 0.04 | 0.666 ± 0.04a |
| pCa for half-maximal force | 6.06 ± 0.03 | 5.96 ± 0.03 |
| Relative force (PO/P4.5) | 0.50 ± 0.04 | 0.52 ± 0.04 |
| a/PO | 0.16 ± 0.04 | 0.20 ± 0.07 |
| Fopt (P/PO) | 0.25 ± 0.02 | 0.27 ± 0.02 |
| Vopt (ML/s) | 0.100 ± 0.012 | 0.117 ± 0.009 |
| Vmax | 0.45 ± 0.09 | 0.47 ± 0.07 |
| PNPO (P/PO*ML/s) | 0.024 ± 0.002 | 0.031 ± 0.002a |
| Submax ktr | 0.456 ± 0.05 | 0.468 ± 0.05 |
| Human samples . | Myofibrillar preparations . | |
|---|---|---|
| Before . | After PKA . | |
| n | 8 | |
| Fiber length (µm) | 153 ± 8 | |
| Fiber width (µm) | 27 ± 2 | |
| Resting sarcomere length (µm) | 2.20 ± 0.02 | |
| Passive force (µN) | 0.53 ± 0.08 | 0.58 ± 0.08 |
| Passive tension (kN/m2) | 1.32 ± 0.18 | 1.39 ± 0.14 |
| Max force (µN) | 14.0 ± 2.3 | 14.7 ± 2.2 |
| Max tension (kN/m2) | 30.9 ± 3.5 | 36.6 ± 4.6a |
| ktr @ pCa 4.5 (s−1) | 0.515 ± 0.04 | 0.666 ± 0.04a |
| pCa for half-maximal force | 6.06 ± 0.03 | 5.96 ± 0.03 |
| Relative force (PO/P4.5) | 0.50 ± 0.04 | 0.52 ± 0.04 |
| a/PO | 0.16 ± 0.04 | 0.20 ± 0.07 |
| Fopt (P/PO) | 0.25 ± 0.02 | 0.27 ± 0.02 |
| Vopt (ML/s) | 0.100 ± 0.012 | 0.117 ± 0.009 |
| Vmax | 0.45 ± 0.09 | 0.47 ± 0.07 |
| PNPO (P/PO*ML/s) | 0.024 ± 0.002 | 0.031 ± 0.002a |
| Submax ktr | 0.456 ± 0.05 | 0.468 ± 0.05 |
Mechanical properties were tested before and after PKA treatment and compared via paired t test analysis. Values are mean ± SEM.
P ≤ 0.05. n equals the number of human hearts (biological replicates), with one cardiac myocyte preparation per heart.